rs35879189
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBA1
The NM_004369.4(COL6A3):βc.8877_8879delβ(p.Ala2960del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.108 in 1,613,878 control chromosomes in the GnomAD database, including 10,585 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.078 ( 626 hom., cov: 31)
Exomes π: 0.11 ( 9959 hom. )
Consequence
COL6A3
NM_004369.4 inframe_deletion
NM_004369.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.80
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_004369.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 2-237336220-TGCA-T is Benign according to our data. Variant chr2-237336220-TGCA-T is described in ClinVar as [Benign]. Clinvar id is 95012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-237336220-TGCA-T is described in Lovd as [Benign]. Variant chr2-237336220-TGCA-T is described in Lovd as [Pathogenic].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A3 | NM_004369.4 | c.8877_8879del | p.Ala2960del | inframe_deletion | 40/44 | ENST00000295550.9 | NP_004360.2 | |
COL6A3 | NM_057166.5 | c.7056_7058del | p.Ala2353del | inframe_deletion | 37/41 | NP_476507.3 | ||
COL6A3 | NM_057167.4 | c.8259_8261del | p.Ala2754del | inframe_deletion | 39/43 | NP_476508.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A3 | ENST00000295550.9 | c.8877_8879del | p.Ala2960del | inframe_deletion | 40/44 | 1 | NM_004369.4 | ENSP00000295550 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0784 AC: 11923AN: 152138Hom.: 626 Cov.: 31
GnomAD3 genomes
AF:
AC:
11923
AN:
152138
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0856 AC: 21412AN: 250082Hom.: 1157 AF XY: 0.0887 AC XY: 12008AN XY: 135376
GnomAD3 exomes
AF:
AC:
21412
AN:
250082
Hom.:
AF XY:
AC XY:
12008
AN XY:
135376
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.111 AC: 162654AN: 1461622Hom.: 9959 AF XY: 0.110 AC XY: 80303AN XY: 727108
GnomAD4 exome
AF:
AC:
162654
AN:
1461622
Hom.:
AF XY:
AC XY:
80303
AN XY:
727108
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0783 AC: 11919AN: 152256Hom.: 626 Cov.: 31 AF XY: 0.0759 AC XY: 5650AN XY: 74436
GnomAD4 genome
AF:
AC:
11919
AN:
152256
Hom.:
Cov.:
31
AF XY:
AC XY:
5650
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
165
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 31, 2012 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 05, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 14, 2017 | - - |
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at